Polymerase Chain Reaction of Plasma and Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciad421 ↗At a glance
Editorial in Clinical Infectious Diseases, 2023. Written by P Lewis White and 1 co-authors. Institution: Public Health Wales Mycology Reference Laboratory, University Hospital of Wales, Cardiff, United Kingdom. Major MEDLINE topics: Aspergillosis, Cell-Free Nucleic Acids. Cited 10 times so far (Crossref); 13 references.
Abstract (original language)
In this editorial commentary, we examine 2 papers reporting the diagnosis of invasive aspergillosis (IA) using polymerase chain reaction (PCR) on plasma samples and bronchoalveolar lavage (BAL) fluid. Mah et al [1] reported the results of a single-center case-control study describing the improved accuracy of Aspergillus PCR targeting cell free DNA (DNAemia) in plasma samples compared with galactomannan enzyme-linked immunosorbent assay (GM) testing. By contrast, Huygens et al [2] conducted a prospective multicenter study to determine the clinical impact of PCR testing for the diagnosis of IA and detection of azole resistance when testing BAL fluid from hematology patients. Both studies used the revised and updated consensus definitions of invasive fungal disease (IFD) published by the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) [2, 3]. In the study of Mah et al, when testing 43 cases of proven/probable IA, as designated by the 2020 EORTC/MSGERC definitions, the sensitivity of PCR was 86.0% (95% confidence interval [CI]: 72.7–93.4%) compared with 63.0% (95% CI: 48.6–75.5%) for serum GM. The PCR sensitivity was not significantly impacted by mold-active prophylaxis confirming recent meta-analyses [4, 5]. Overall, the specificity of PCR was comparable to GM (93.1% vs 93.0%) when testing 130 patients with no evidence of IA and PCR was more useful for both confirming and excluding IA compared with GM. When applying a positivity threshold requiring 2 consecutive PCR-positive results, sensitivity remained excellent, but specificity data were not provided. Given that the specificity for Aspergillus PCR utilizing a single positive threshold is already excellent, the requirement for consecutive positive results should enhance this further and supports the current requirement for consecutive blood samples being Aspergillus PCR positive before they are considered as an EORTC/MSGERC mycological criterion for IA [1–3].
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Public Health Wales Mycology Reference Laboratory, University Hospital of Wales, Cardiff, United Kingdom.
- Fungal PCR Initiative, Nijmegen, The Netherlands.
ORCID profiles: P Lewis White
Cite
APA
White, P. L., & Donnelly, J. P. (2023). Polymerase Chain Reaction of Plasma and Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad421
Vancouver
White PL, Donnelly JP. Polymerase Chain Reaction of Plasma and Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad421
BibTeX
@article{White2023,
author = {White, P Lewis and Donnelly, J Peter},
title = {Polymerase Chain Reaction of Plasma and Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciad421}
}
EUVIMED